ATE169014T1 - Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament - Google Patents
Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikamentInfo
- Publication number
- ATE169014T1 ATE169014T1 AT95907860T AT95907860T ATE169014T1 AT E169014 T1 ATE169014 T1 AT E169014T1 AT 95907860 T AT95907860 T AT 95907860T AT 95907860 T AT95907860 T AT 95907860T AT E169014 T1 ATE169014 T1 AT E169014T1
- Authority
- AT
- Austria
- Prior art keywords
- compound
- same
- potassium salt
- medication containing
- mono
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- ZWZGXLKXKAPXMZ-UHFFFAOYSA-N 2,2'-dihydroxy-3,3'-dimethoxy-5,5'-dipropyldiphenylmethane Chemical class COC1=CC(CCC)=CC(CC=2C(=C(OC)C=C(CCC)C=2)O)=C1O ZWZGXLKXKAPXMZ-UHFFFAOYSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 2
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 abstract 2
- 229940123413 Angiotensin II antagonist Drugs 0.000 abstract 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1622094 | 1994-02-10 | ||
| JP12873994 | 1994-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE169014T1 true ATE169014T1 (de) | 1998-08-15 |
Family
ID=26352497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95907860T ATE169014T1 (de) | 1994-02-10 | 1995-02-08 | Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0744402B1 (de) |
| KR (1) | KR970700672A (de) |
| CN (1) | CN1140450A (de) |
| AT (1) | ATE169014T1 (de) |
| CA (1) | CA2181260A1 (de) |
| DE (1) | DE69503760T2 (de) |
| DK (1) | DK0744402T3 (de) |
| ES (1) | ES2120180T3 (de) |
| GR (1) | GR3027777T3 (de) |
| WO (1) | WO1995021837A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69507887T2 (de) * | 1994-09-20 | 1999-06-17 | Wakunaga Seiyaku K.K., Osaka | Verfahren zur herstellung von n-biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen |
| KR19990022836A (ko) * | 1995-06-27 | 1999-03-25 | 기스케 와구나가, 구사이 요시히로 | 테트라졸릴화 비페닐메탄 유도체의 제조방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993017681A1 (en) * | 1992-03-02 | 1993-09-16 | Abbott Laboratories | Angiotensin ii receptor antagonists |
| WO1994004516A1 (fr) * | 1992-08-11 | 1994-03-03 | Wakunaga Seiyaku Kabushiki Kaisha | Derive de biphenylmethane et medicament le contenant |
| DE69507887T2 (de) * | 1994-09-20 | 1999-06-17 | Wakunaga Seiyaku K.K., Osaka | Verfahren zur herstellung von n-biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen |
-
1995
- 1995-02-08 CN CN95191557A patent/CN1140450A/zh active Pending
- 1995-02-08 EP EP95907860A patent/EP0744402B1/de not_active Expired - Lifetime
- 1995-02-08 DE DE69503760T patent/DE69503760T2/de not_active Expired - Fee Related
- 1995-02-08 KR KR1019960704121A patent/KR970700672A/ko not_active Ceased
- 1995-02-08 ES ES95907860T patent/ES2120180T3/es not_active Expired - Lifetime
- 1995-02-08 CA CA002181260A patent/CA2181260A1/en not_active Abandoned
- 1995-02-08 AT AT95907860T patent/ATE169014T1/de not_active IP Right Cessation
- 1995-02-08 DK DK95907860T patent/DK0744402T3/da active
- 1995-02-08 WO PCT/JP1995/000174 patent/WO1995021837A1/ja not_active Ceased
-
1998
- 1998-08-31 GR GR980401955T patent/GR3027777T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0744402A1 (de) | 1996-11-27 |
| GR3027777T3 (en) | 1998-11-30 |
| EP0744402A4 (de) | 1997-03-26 |
| AU1591295A (en) | 1995-08-29 |
| DE69503760T2 (de) | 1998-12-17 |
| KR970700672A (ko) | 1997-02-12 |
| WO1995021837A1 (en) | 1995-08-17 |
| ES2120180T3 (es) | 1998-10-16 |
| EP0744402B1 (de) | 1998-07-29 |
| DE69503760D1 (de) | 1998-09-03 |
| AU685586B2 (en) | 1998-01-22 |
| CA2181260A1 (en) | 1995-08-17 |
| CN1140450A (zh) | 1997-01-15 |
| DK0744402T3 (da) | 1999-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE122006000051I1 (de) | Ester der 5-Aminolevulins{ure als Mittel zur Photosensibillisierung in der Chemotherapie | |
| TNSN04246A1 (fr) | Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation | |
| TNSN05165A1 (fr) | Derives de pyrrolopyrimidine | |
| GEP20002298B (en) | Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment | |
| ATE164080T1 (de) | Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole | |
| BRPI0409427A (pt) | composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo | |
| LV12291A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
| ATE210118T1 (de) | N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten | |
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| ATE268174T1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
| BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
| ATE101138T1 (de) | Parabansaeure-derivate und pharmazeutische zusammensetzungen damit. | |
| ATE169014T1 (de) | Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament | |
| DE69217613D1 (de) | Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| DE10299023I2 (de) | Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff | |
| KR950702544A (ko) | 비페닐메탄 유도체 및 이를 함유하는 약제 | |
| ATE331523T1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| EP2266566A3 (de) | Nicotinamid Derivate und ihrer Verwendung als Therapeutika | |
| ATE192748T1 (de) | Neue alkaloidderivate, ihre verwendung und diese enthaltende pharmazeutische formulierungen | |
| DK1142575T3 (da) | Lægemidler til tör hud | |
| FR2845087B1 (fr) | Nouveaux acides arylhexadienoiques substitues et leurs esters,utilisables dans le traitement et la prevention du diabete, des dyslipidemies,de l'atherosclerose, compositions pharmaceutiques les contenant et procedes de preparation | |
| NO961180L (no) | Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom | |
| GEP20043356B (en) | Compounds Useful For Treatment or Prevention of Diseases Mediated By Alpha- 2B-Adrenoceptor | |
| TH16370A (th) | สารประกอบไดแอริล | |
| MD940244A (ro) | Derivaţi noi ai tetrazolului, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |